Abstract. When kakkalide, which was isolated from Flos Puerariae, was incubated with human fecal bacteria, kakkalide was metabolized to irisolidone via kakkalidone. When kakkalide (250 mg / kg) was orally administered to rats, irisolidone, but not kakkalide, was detected in the blood. The mortality associated with ethanol treatment was slightly reduced when the mice were intraperitoneally treated with kakkalide. Intraperitoneally administered kakkalide and kakkalidone did not reduce alcohol toxicity. However, orally administered kakkalide and intraperitoneally administered irisolidone significantly reduced the mortality. Orally administered kakkalide and intraperitoneally injected irisolidone greatly reduced serum alanine aminotransferase and aspartate aminotransferase activities in ethanol-intoxified mice. Orally administered kakkalide and intraperitoneally administered irisolidone significantly lowered the level of blood ethanol. The results indicate that kakkalide is a prodrug of irisolidone in protecting against ethanol-induced lethality and hepatic injury.
Introduction
In traditional Chinese medicine, Flos Puerariae is used in therapy to counteract problems associated with alcohol drinking (1). Niiho et al. (2, 3) reported that the isoflavonoid fraction of Flos Puerariae suppressed the increase in the concentration of blood ethanol, acetaldehyde, and ketones induced by ethanol administration and that its isoflavonoid and triterpenoid saponin fractions improved both the abnormal metabolism induced by ethanol and hepatic injuries induced by carbon tetrachloride or high-fat food. Jang et al. (4) reported that Puerariae Radix inhibited cell proliferation and nitric oxide synthetase expression in dentate gyrus of alcohol-intoxificated Sprague-Dawley rats. Yamazaki et al. (5) reported that intraperitoneally administered kakkalide, which was isolated from Flos Puerariae, reduced mortality associated with administration of ethanol and serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities.
Most traditional medicinal herbs are orally administered and their components inevitably come into contact with intestinal microflora in the alimentary tract. The chemical components of herbs can be transformed by intestinal bacteria before being absorbed from the gastrointestinal tract. We reported that isoflavone glycosides 6''-O-xylosyltectoridin and tectoridin were metabolized to tectorigenin by human intestinal microflora (6) . The pharmacological activity produced by intraperitoneal administration of kakkalide could be different from that produced by its oral administration. Therefore, we isolated two metabolites, irisolidone and kakkalidone, from the biotransformation of kakkalide by human fecal bacteria and then investigated their effects on ethanol-induced lethality and acute hepatic injury.
Materials and Methods

Materials
Kakkalide was isolated according to our previous method (7) . Alcohol assay kit, ALT assay kit, and AST assay kit were purchased from Sigma Co. (St. Louis, MO, USA).
Extraction and isolation of metabolites
To obtain the metabolites of kakkalide by human intestinal bacteria, a reaction mixture was prepared containing 0.5 g kakkalide and 0.5 g fresh human feces in a final volume of 100 ml of anaerobic dilution medium according to the procedure of Hattori et al. (8) . The mixture was anaerobically incubated at 37°C for 20 h in an anaerobic glove box (Coy Laboratory Products, Inc., Grass Lake, MI, USA), and then the reaction mixture was extracted three times with ethyl acetate. The EtOAc-soluble portion of the reaction mixture was dried on a rotary evaporator under reduced pressure and subjected to silica-gel column (2.5´15 cm) chromatography (Silica gel 60 [0.063 -0.200 mm]; Merck Co., Darmstadt, Germany) with CHCl 3 / MeOH (10:1 ® 10:2). From these fractions incubated with kakkalide, kakkalidone (irisolidone-7-O-b-D-glucopyranoside) and irisolidone were obtained and identified by comparison with the physicochemical data in the literature (7, 9, 10 The time-course of the metabolism of kakkalide by human fecal bacteria was measured as follows: A reaction mixture containing 0.4 mM kakkalide and 0.1 g fresh human feces in a final volume of 20 ml of GAM broth was incubated at 37°C for 24 h and an aliquot (1 ml) of the reaction mixture was periodically extracted twice with 5 ml ethyl acetate. Metabolites in the ethyl acetate fraction were analyzed by HPLC (column, mBondak-C18 4.0´250 mm; mobile phase, 1 / 75M KH 2 PO 4 :MeOH = 1:1; flow rate, 1 ml / min; detection, 280 nm; internal standard, hesperetin).
Animals
Male ICR strain mice weighing 20 -25 g and Sprague Dawley rats weighing 230 -250 g (Daehan Animal Center, Eumsung, Korea) were maintained in an airconditioned room with lighting from 07:00 to 19:00.
The room temperature (22 ± 2°C) and humidity (55 ± 10%) were controlled automatically. A laboratory pellet chow (Samyang, Seoul, Korea) and water were freely available. The procedures involving animals and their care conformed to the international guidelines Principles of Laboratory Aminals Care (NIH publication No. 85-23, revised 1985) and Guiding Principles for the Care and Use of Laboratory Animals of Kyung Hee University, Korea.
Alcohol toxicity experiments
According to the previously reported method of Yamazaki et al. (5), ICR mice were fasted overnight; administered a test compound (suspended in 1% carboxylmethylcellulose [CMC]) intraperitoneally or orally; and then 30 min later, intraperitoneally injected with 25% ethanol (7.5 g / kg) in saline. The control group received the vehicle alone instead of the test compound. At 24 h after ethanol injection, the number of dead mice were counted.
Ethanol-induced acute hepatic injury
According to the previously reported method of Yamazaki et al. (5), ICR mice were fasted for 9 -10 h; a test compound (suspended in 1% CMC) was administered intraperitoneally or orally; and 30 min later, 25% ethanol (5.0 g / kg) in saline was injected intraperitoneally. The control group received vehicle alone instead of the test compound. The mice were killed by cervical dislocation 15 h after ethanol administration and whole-blood samples were immediately withdrawn from carotid artery. Sera were obtained by centrifugation for 10 min at 250´g and then assayed for ALT and AST activities. ALT and AST activities were measured by the method of Reitman and Frankel (11) .
Assay of blood alcohol content
According to the method of Yamazaki et al. (5), ICR mice were fasted for 9 -10 h, and then they were intraperitoneally injected with 25% ethanol (5.0 g / kg) in saline either before or 30 min after intraperitoneal or oral administration of a test compound suspended in 1% CMC. The control group received vehicle alone instead of the test compound. The mice were killed by cervical dislocation 2 h after ethanol administration. Whole blood samples were immediately withdrawn from the carotid artery, treated with 6.25% trichloroacetic acid, centrifuged for 10 min at 1200 rpm, and assayed for alcohol by the method of Bucher and Redetzki (12) .
Pharmacokinetic study
To facilitate blood sampling, male Sprague-Dawley rats weighing 230 -250 g were anesthetized with thiopental sodium and then subjected to femoral artery cannulation with a 30-cm-long fragment of polyethylene (PE 50) tube, with free end of the cannula being subcutaneously conducted to the dorsal base of the neck. The externalized end was closed with a polyethylene plug. The cannula was permanently filled with heparinized saline solution. Kakkalide (250 mg / kg) was orally administered, and blood samples were collected continuously at 0.5, 1, 3, and 6 h post-dosing. The plasma sample (0.5 ml) was immediately deproteinated with 5 ml methanol and centrifuged at 1500´g for 2 min (This procedure was repeated). The methanol fraction was evaporated and dissolved in 0.2 ml methanol and assayed for kakkalide, kakkalidone, and irisolidone concentrations by HPLC (column, m -Bondak-C18 4.02 50 mm; mobile phase, 1 / 75M KH 2 PO 4 :MeOH = 1:1; flow rate, 1 ml / min; detection, 280 nm; internal standard, hesperetin; Younglin Co., Seoul, Korea).
Statistical analyses
All the data from the in vivo experiments were expressed as the mean ± S.D. and statistical significance was determined by Student's t-test and the c 2 -test.
Results
Metabolism of kakkalide by human fecal bacteria
When kakkalide was incubated with human fecal bacteria, irisolidone and kakkalidone were isolated as metabolites (Fig. 1) . Kakkalide was mainly metabolized to irisolidone. The level of kakkalide metabolism by different human fecal specimens was different, but detected in all specimens. The fecal suspensions of rats also metabolized kakkalide to irisolidone, with a metabolic pattern similar to those of humans.
To understand the biotransformation of kakkalide in the whole body, kakkalide (250 mg / kg) was orally administered to rats and the compounds absorbed from the intestine into blood were analyzed by HPLC. As shown in Fig. 2 , the main metabolite detected was irisolidone, but no kakkalide was detected.
Protective effect of kakkalide and its metabolites on alcohol toxicity
To determine the active form of kakkalide that is responsible for the protection against alcohol toxicity, metabolites of kakkalide by human intestinal microflora were isolated, and their effects on alcohol toxicity were investigated (Table 1) . When ethanol was intraperitoneally administered to mice, the mortality at 24 h postdosing was 60%. The mortality was slightly reduced to 40% when the mice were intraperitoneally treated with kakkalide (50 mg / kg) 30 min before ethanol administration. Intraperitoneally administered kakkalidone did not reduce alcohol toxicity. However, orally administered kakkalide at 50 mg / kg reduced mortality significantly to 10%. Intraperitoneally administered irisolidone exhibited the most potent protective activity on alcohol toxicity; the mortality was reduced to 10% in irisolidone-treated (25 mg/ kg, i.p.) mice.
Effect of kakkalide and irisolidone on ethanol-induced acute hepatic injury
After the intraperitoneal injection of ethanol at a dose of 5.0 g / kg, serum ALT and AST activities were significantly increased when compared with the normal group. While all the test compounds ameliorated the ethanolinduced increases in ALT and AST activities, kakkalide (p.o.) and irisolidone (i.p.) greatly reduced serum ALT and AST activities when compared with the control group ( Table 2) . Although kakkalidone (i.p.) and kakkalide (i.p.) significantly reduced serum ALT activity (not AST), their inhibitory effects were very weak. However, irisolidone potently reduced serum ALT and AST activity. The hepatoprotective effect of irisolidone at the dose of 100 mg/ kg was more potent than that of kakkalide at the dose of 200 mg / kg, which is a similar concentration on a molar basis.
Effect of kakkalide and irisolidone on serum ethanol level in ethanol-administered mice
Kakkalide or irisolidone was intraperitoneally or orally administered to mice prior to or after the ethanol injection (Table 3) . Pre-oral administration of kakkalide and pre-or post-administration of irisolidone significantly reduced blood ethanol level. Notably, irisolidone treatment after the ethanol injection decreased blood ethanol level to a larger degree than that of the dose given prior to ethanol injection. However, intraperitoneal pre-and post-administrations of kakkalide and kakklidone did not decrease blood ethanol level. The ethanol lowering effect of irisolidone at the dose of 100 mg / kg was more potent than those of kakkalide at the dose of 200 mg/ kg, which is a similar concentration on a molar basis.
Discussion
Kurihara and Kikuchi (10) isolated a new isoflavone glycoside, kakkalide, from Flos Puerariae, a commonly used herb in traditional Chinese medicine to counteract the adverse effect of alcohol drinking. Yamazaki et al. (5) reported that intraperitoneally administered kakkalide reduced mortality and serum ALT and AST activities associated with administration of ethanol.
While Flos Puerariae is taken orally in traditional usage, the pharmacological effect of intraperitoneally administered kakkalide agreed with that of orally administered Flos Puerariae. After incubating kakkalide with human intestinal microflora, irisolidone and kakkalidone were isolated, with irisolidone being the main metabolite. When kakkalide was orally administered to rats, irisolidone, but not kakkalide, was detected in the blood. This indicates that kakkalide is metabolized to irisolidone via kakkalidone by virtue of the biotransformation reactions occurring in intestinal bacteria (Fig. 3) . Therefore, the pharmacological effect of orally administered kakkalide should be similar to those of the intraperitoneally injected irisolidone.
Irisolidone greatly reduced the ethanol-induced mortality and serum ALT and AST activities. Furthermore, both the pre-and post-treatment with kakkalide (p.o.) and irisolidone (i.p.) were found to reduce blood ethanol level. In contrast, intraperitoneally administered kakkalide did not reduce the ethanol level in blood. Suda et al. (13) have suggested that the lethal effect of ethanol may arise from hepatotoxicity or exorbitant sympathominetic activity caused by increased catecholamines. Irisolidone, but not kakkalide, reduced the mortality at 24 h post-ethanol treatment. These results indicate that the orally administered kakkalide has to be transformed to irisolidone by intestinal bacteria, thereby producing the detoxifying effect on ethanol.
Measurement of serum ALT and AST activities is one of the most widely used means for assessing the extent of hepatic damage. Administration of ethanol casued increases in serum ALT and AST activities, which is indicative of liver injury. Our results are consistent with the finding that a methanolic extract isolated from Flos Puerariae exhibited hepatoprotective and blood ethanol lowering effects (3). In addition, Klingman and Haag (14) indicated that injection of a large dose of ethanol resulted in an increase in serum catecholamine content. Yoshihara et al. (15) reported that ethanol-induced hyperadrenalinemia caused hepatic injury, presumblly mediated by the suppression of hepatic blood flow.
In conclusion, the results suggest that both orally administered kakkalide and intraperitoneally administered irisolidone protect against ethanol-induced mortality and hepatic injury, and kakkalide is a prodrug, which is metabolized to form the bioactive irisolidone by intestinal microflora.
